The framework of the upcoming US sales channel for over-the-counter (OTC) hearing aids was recently made public, and the big hearing aid manufacturers have been reading the over 100-page document from the US Food and Drug Administration carefully.
So far, CEO at GN Hearing Gitte Aabo's opinion is positive, she explains.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app